@article{e9064327a6fb4ee5a83bb1a1ca791f5a,
title = "Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis",
abstract = "Hydroxyethyl starch (HES) [corrected] is widely used for fluid resuscitation in intensive care units (ICUs), but its safety and efficacy have not been established in patients with severe sepsis.",
keywords = "Aged, Double-Blind Method, Female, Fluid Therapy, Hemorrhage, Hetastarch, Humans, Intention to Treat Analysis, Isotonic Solutions, Kidney Failure, Chronic, Male, Middle Aged, Renal Replacement Therapy, Sepsis",
author = "Anders Perner and Nicolai Haase and Guttormsen, {Anne B} and Jyrki Tenhunen and Gudmundur Klemenzson and Anders {\AA}neman and Madsen, {Kristian R} and M{\o}ller, {Morten H} and Elkj{\ae}r, {Jeanie M} and Poulsen, {Lone M} and Asger Bendtsen and Robert Winding and Morten Steensen and Pawel Berezowicz and Peter S{\o}e-Jensen and Morten Bestle and Kristian Strand and J{\o}rgen Wiis and White, {Jonathan O} and Thornberg, {Klaus J} and Lars Quist and Jonas Nielsen and Andersen, {Lasse H} and Holst, {Lars B} and Katrin Thormar and Anne-Lene Kj{\ae}ldgaard and Fabritius, {Maria L} and Frederik Mondrup and Pott, {Frank C} and M{\o}ller, {Thea P} and Per Winkel and J{\o}rn Wetterslev and {6S Trial Group}",
year = "2012",
doi = "10.1056/NEJMoa1204242",
language = "English",
volume = "367",
pages = "124--34",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachusetts Medical Society",
number = "2",
}